A J Kraker

Statistics

Publications

Citations

995

H-Index

Active since

1980

Affiliations

University of Wisconsin–Milwaukee(Current)

University of Auckland

Moffitt Cancer Center

A J Kraker is an author at University of Wisconsin–Milwaukee specializing in pharmacology, tyrosine kinase inhibition, and tyrosine kinase inhibitors.

Publications per year

1980–2002

Publications

Ligand substitution reactions of metallothioneins with EDTA and apo-carbonic anhydrase.

T Y Li, A J Kraker, C. Frank Shaw et al. · Proceedings of the National Academy of Sciences · 1980 · 186 citations · Full text

Natural Sciences, Biochemistry, Chemistry +15

The pyrido[2,3-d]pyrimidine derivative PD180970 inhibits p210Bcr-Abl tyrosine kinase and induces apoptosis of K562 leukemic cells.

Jay F. Dorsey, Richard Jove, A J Kraker et al. · PubMed · 2000 · 154 citations

Life Sciences, Oncology, Pharmacology +17

Tyrosine kinase inhibitors. 7. 7-amino-4-(phenylamino)- and 7-amino-4-[(phenylmethyl)amino]pyrido[4,3-d]pyrimidines: a new class of inhibitors of the tyrosine kinase activity of the epidermal growth factor receptor

Andrew M. Thompson, Alexander J. Bridges, David W. Fry et al. · Journal of Medicinal Chemistry · 1995 · 142 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

Accumulation of cis-diamminedichloroplatinum(II) and platinum analogues by platinum-resistant murine leukemia cells in vitro.

A J Kraker, Charles Watson Moore · PubMed · 1988 · 121 citations

Medicine, Oncology, Pharmacology +13

Therapeutic targeting of Src-kinase Lyn in myeloid leukemic cell growth

Vera Roginskaya, Sherry Zuo, Eva G. Caudell et al. · Leukemia · 1999 · 89 citations

Medicine, Cancer Biology, Oncology +16

1–5 of 13